OBSIDIAN THERAPEUTICS Trademark

Trademark Overview

On Monday, March 7, 2016, a trademark application was filed for OBSIDIAN THERAPEUTICS with the United States Patent and Trademark Office. The USPTO has given the OBSIDIAN THERAPEUTICS trademark a serial number of 86931311. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, October 21, 2019. This trademark is owned by Obsidian Therapeutics. The OBSIDIAN THERAPEUTICS trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Pharmaceutical research and development in the field of gene therapy
obsidian therapeutics

General Information

Serial Number86931311
Word MarkOBSIDIAN THERAPEUTICS
Filing DateMonday, March 7, 2016
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, October 21, 2019
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, July 26, 2016

Trademark Statements

Indication of Colors claimedColor is not claimed as a feature of the mark.
Disclaimer with Predetermined Text"THERAPEUTICS"
Description of MarkThe mark consists of the word "OBSIDIAN" located above the word "THERAPEUTICS" and to the right of a series of triangles and quadrilaterals contained within a hexagon.
Goods and ServicesPharmaceutical research and development in the field of gene therapy

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateSaturday, March 12, 2016
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameObsidian Therapeutics
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressCambridge, MA 02138
Party NameObsidian Therapeutics
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCambridge, MA 02139

Trademark Events

Event DateEvent Description
Monday, October 21, 2019ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, October 21, 2019ABANDONMENT - NO USE STATEMENT FILED
Saturday, March 16, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, March 15, 2019EXTENSION 5 GRANTED
Monday, March 11, 2019EXTENSION 5 FILED
Friday, March 15, 2019CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, March 11, 2019TEAS EXTENSION RECEIVED
Thursday, September 6, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, September 4, 2018EXTENSION 4 GRANTED
Tuesday, September 4, 2018EXTENSION 4 FILED
Tuesday, September 4, 2018TEAS EXTENSION RECEIVED
Saturday, March 17, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, March 15, 2018EXTENSION 3 GRANTED
Thursday, March 15, 2018EXTENSION 3 FILED
Thursday, March 15, 2018TEAS EXTENSION RECEIVED
Wednesday, September 13, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, September 11, 2017EXTENSION 2 GRANTED
Monday, September 11, 2017EXTENSION 2 FILED
Monday, September 11, 2017TEAS EXTENSION RECEIVED
Tuesday, August 15, 2017APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, August 15, 2017TEAS CHANGE OF OWNER ADDRESS RECEIVED
Wednesday, March 15, 2017APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, March 15, 2017TEAS CHANGE OF OWNER ADDRESS RECEIVED
Thursday, February 16, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, February 14, 2017EXTENSION 1 GRANTED
Tuesday, February 14, 2017EXTENSION 1 FILED
Tuesday, February 14, 2017TEAS EXTENSION RECEIVED
Tuesday, February 14, 2017TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, September 20, 2016NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, July 26, 2016OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, July 26, 2016PUBLISHED FOR OPPOSITION
Wednesday, July 6, 2016NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, June 21, 2016LAW OFFICE PUBLICATION REVIEW COMPLETED
Monday, June 13, 2016APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, June 13, 2016EXAMINER'S AMENDMENT ENTERED
Monday, June 13, 2016NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Monday, June 13, 2016EXAMINERS AMENDMENT E-MAILED
Monday, June 13, 2016EXAMINERS AMENDMENT -WRITTEN
Monday, June 13, 2016PREVIOUS ALLOWANCE COUNT WITHDRAWN
Friday, June 10, 2016ASSIGNED TO LIE
Thursday, June 2, 2016TEAS VOLUNTARY AMENDMENT RECEIVED
Thursday, June 2, 2016APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, June 1, 2016TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, June 1, 2016CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, June 1, 2016TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, May 23, 2016TEAS CHANGE OF CORRESPONDENCE RECEIVED
Sunday, May 22, 2016NOTIFICATION OF NON-FINAL ACTION E-MAILED
Sunday, May 22, 2016NON-FINAL ACTION E-MAILED
Sunday, May 22, 2016NON-FINAL ACTION WRITTEN
Friday, May 20, 2016ASSIGNED TO EXAMINER
Tuesday, March 15, 2016NOTICE OF DESIGN SEARCH CODE E-MAILED
Saturday, March 12, 2016NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Thursday, March 10, 2016NEW APPLICATION ENTERED IN TRAM

Related Keywords

therapeutics obsidian gene therapy field development research pharmaceutical